Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

Giri Jay; Nathan Ashwin

首页> 外文期刊>JACC. Cardiovascular interventions >Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

【24h】

Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

机译：是在抗凝患者经皮冠状动脉介入后放弃双抗血小板治疗的时间吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《JACC. Cardiovascular interventions》 |2018年第7期|共3页
作者
Giri Jay; Nathan Ashwin;
展开▼
作者单位

Univ Penn Perelman Sch Med Cardiovasc Med Div Penn Ctr Cardiovasc Outcomes Qual &

Evaluat Res;

Univ Penn Perelman Sch Med Cardiovasc Med Div Penn Ctr Cardiovasc Outcomes Qual &

Evaluat Res;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词
antiplatelet therapy; atrial fibrillation; novel anticoagulants; PCI;

机译：抗血小板疗法;心房颤动;新的抗凝血剂;PCI;

相似文献

外文文献
中文文献
专利

1. Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation? [J] . Giri Jay, Nathan Ashwin JACC. Cardiovascular interventions . 2018,第7期

机译：是在抗凝患者经皮冠状动脉介入后放弃双抗血小板治疗的时间吗？
2. Meta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent Implantation [J] . Bowen Lou, Xiao Liang, Yue Wu, The American Journal of Cardiology . 2018,第4期

机译：Meta分析与单一抗血小板治疗的患者与抗血栓治疗组合的荟萃分析与心房颤动的患者组合，植入支架植入术治疗
3. Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention [J] . Hoshi Tomoya, Sato Akira, Nogami Akihiko, Journal of cardiology . 2017,第3a4期

机译：安全研究的理由与设计：贲门班与双抗血小板治疗的安全性和有效性试验在经皮冠状动脉介入的心房颤动患者中
4. Incidence of Atrial Fibrillation After Percutaneous Closure of Patent Foramen Ovale and Small Atrial Septal Defects in Patients Presenting with Cryptogenic Stroke: A Case-Control Study [C] . R.F. Bonvini, R. Sztajzel, M. Righini, World Congress on Heart Disease . 2007

机译：用密码脑卒中患者经皮型卵形卵形卵形卵巢经皮和小间隔缺陷后心房颤动的发生率：案例对照研究
5. Early Identification and Intervention in Patients with Atrial Fibrillation Using an Implantable Cardiac Monitor to Significantly Improve Guideline-Based Anticoagulation Therapy in an Outpatient Cardiology Clinic [D] . Alvarez, Lisa 2019

机译：使用可植入式心脏监护仪对房颤患者的早期识别和干预，可显着改善门诊心脏病学诊所基于指南的抗凝治疗
6. For Patients Needing Oral Anticoagulation for Atrial Fibrillation and Dual Antiplatelet Therapy after Percutaneous Coronary Intervention Is Double Therapy Preferred over Triple Therapy? [O] . 2019

机译：对于经皮冠状动脉介入治疗后需要口服抗凝治疗房颤和双重抗血小板治疗的患者双重治疗优于三联治疗吗？
7. SHOULD ANTICOAGULATION THERAPY BE COMBINED WITH DUAL ANTIPLATELET THERAPY IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION FOLLOWING PERCUTANEOUS CORONARY INTERVENTION? [O] . Ho Kay Woon, Ivanov Joan, Seidelin Peter, 2012

机译：在经冠状动脉介入治疗后非瓣膜性心房颤动的患者中，应将抗凝治疗与双重抗血小板治疗相结合吗？

Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

著录项

相似文献

相关主题

期刊订阅